Melhores Radioterapia para cancro do pulmão médicos em Israel - TOP-4 médicos

Chefe da Unidade de Oncologia de Tecidos Moles e Ósseos no Centro Médico Sourasky – O Prof. Merimsky é especializado em casos complexos de câncer de pulmão.

• Mais de 25 anos de experiência em oncologia
• Fellowship (Bolsa de Estudos) em sarcoma de tecidos moles e ósseos no Institut Gustave Roussy
• Membro do corpo docente do grupo Sarcoma da ESMO
• Publicou extensivamente sobre os resultados do tratamento oncológico

O Dr. Ari Raphael é um especialista líder em radioterapia do cancro do pulmão, com um forte foco em perfil genómico avançado e ensaios clínicos.

• Professor sénior e oncologista médico no Sourasky Medical Center
• Líder do projeto da Iniciativa Nacional de Medicina Genómica de Israel
• Investigador principal de estudos inovadores sobre imunoterapia para o CPNC
• Membro de sociedades europeias e internacionais de oncologia torácica
• Prémio de professor de excelência da faculdade de medicina da Universidade de Tel-Aviv

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.